LancerinCAS# 81991-99-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 81991-99-3 | SDF | Download SDF |
PubChem ID | 5281645 | Appearance | Powder |
Formula | C19H18O10 | M.Wt | 406.34 |
Type of Compound | Xanthones | Storage | Desiccate at -20°C |
Solubility | Soluble in DMSO and methanol; insoluble in water | ||
Chemical Name | 1,3,7-trihydroxy-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one | ||
SMILES | C1=CC2=C(C=C1O)C(=O)C3=C(O2)C(=C(C=C3O)O)C4C(C(C(C(O4)CO)O)O)O | ||
Standard InChIKey | JUZGXATTXYZBGK-HBVDJMOISA-N | ||
Standard InChI | InChI=1S/C19H18O10/c20-5-11-15(25)16(26)17(27)19(29-11)13-9(23)4-8(22)12-14(24)7-3-6(21)1-2-10(7)28-18(12)13/h1-4,11,15-17,19-23,25-27H,5H2/t11-,15-,16+,17-,19+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Lancerin Dilution Calculator
Lancerin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.461 mL | 12.305 mL | 24.6099 mL | 49.2199 mL | 61.5248 mL |
5 mM | 0.4922 mL | 2.461 mL | 4.922 mL | 9.844 mL | 12.305 mL |
10 mM | 0.2461 mL | 1.2305 mL | 2.461 mL | 4.922 mL | 6.1525 mL |
50 mM | 0.0492 mL | 0.2461 mL | 0.4922 mL | 0.9844 mL | 1.2305 mL |
100 mM | 0.0246 mL | 0.123 mL | 0.2461 mL | 0.4922 mL | 0.6152 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Vitedoin A
Catalog No.:BCN6741
CAS No.:819861-40-0
- Hyperxanthone E
Catalog No.:BCN8072
CAS No.:819860-76-9
- KW-2478
Catalog No.:BCC2127
CAS No.:819812-04-9
- Clovin
Catalog No.:BCN7817
CAS No.:81970-00-5
- Splendoside
Catalog No.:BCN6647
CAS No.:81969-41-7
- 4(15),5,10(14)-Germacratrien-1-ol
Catalog No.:BCN4354
CAS No.:81968-62-9
- Z-Ligustilide
Catalog No.:BCC9193
CAS No.:81944-09-4
- Zofenopril calcium
Catalog No.:BCC5229
CAS No.:81938-43-4
- Polyphyllin H
Catalog No.:BCN2834
CAS No.:81917-50-2
- Momordicoside I aglycone
Catalog No.:BCN4353
CAS No.:81910-41-0
- 5,19-Epoxy-25-methoxycucurbita-6,23-dien-3-ol
Catalog No.:BCN1341
CAS No.:81910-39-6
- Ganoderic acid A
Catalog No.:BCN3033
CAS No.:81907-62-2
- Khellin
Catalog No.:BCN4356
CAS No.:82-02-0
- Benzanthrone
Catalog No.:BCC8845
CAS No.:82-05-3
- Rottlerin
Catalog No.:BCC7127
CAS No.:82-08-6
- Alpha-Toxicarol
Catalog No.:BCN6467
CAS No.:82-09-7
- 1-Amino-2-methylanthraquinone
Catalog No.:BCC8451
CAS No.:82-28-0
- Visnagin
Catalog No.:BCN4367
CAS No.:82-57-5
- Peri acid
Catalog No.:BCC9116
CAS No.:82-75-7
- 8-Anilino-1-naphthalenesulfonic acid
Catalog No.:BCC8785
CAS No.:82-76-8
- Daurichromenic acid
Catalog No.:BCN4355
CAS No.:82003-90-5
- 10Z-Hymenialdisine
Catalog No.:BCC5773
CAS No.:82005-12-7
- Boc-Leucinol
Catalog No.:BCC2724
CAS No.:82010-31-9
- Loteprednol etabonate
Catalog No.:BCC4916
CAS No.:82034-46-6
2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide Radical (PTIO*) Trapping Activity and Mechanisms of 16 Phenolic Xanthones.[Pubmed:29997352]
Molecules. 2018 Jul 11;23(7). pii: molecules23071692.
This study used the 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide radical (PTIO*) trapping model to study the antioxidant activities of 16 natural xanthones in aqueous solution, including garcinone C, gamma-mangostin, subelliptenone G, mangiferin, 1,6,7-trihydroxy-xanthone, 1,2,5-trihydroxyxanthone, 1,5,6-trihydroxyxanthone, norathyriol, 1,3,5,6-tetrahydroxy-xanthone, isojacareubin, 1,3,5,8-tetrahydroxyxanthone, isomangiferin, 2-hydroxyxanthone, 7-O-methylmangiferin, neomangiferin, and Lancerin. It was observed that most of the 16 xanthones could scavenge the PTIO* radical in a dose-dependent manner at pH 4.5 and 7.4. Among them, 12 xanthones of the para-di-OHs (or ortho-di-OHs) type always exhibited lower half maximal inhibitory concentration (IC50) values than those not of the para-di-OHs (or ortho-di-OHs) type. Ultra-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry (UPLC-ESI-Q-TOF-MS/MS) analysis revealed that most of these xanthones gave xanthone-xanthone dimers after incubation with PTIO*, except for neomangiferin. Based on these data, we concluded that the antioxidant activity of phenolic xanthone may be mediated by electron-transfer (ET) plus H(+)-transfer mechanisms. Through these mechanisms, some xanthones can further dimerize unless they bear huge substituents with steric hindrance. Four substituent types (i.e., para-di-OHs, 5,6-di-OHs, 6,7-di-OHs, and 7,8-di-OHs) dominate the antioxidant activity of phenolic xanthones, while other substituents (including isoprenyl and 3-hydroxy-3-methylbutyl substituents) play a minor role as long as they do not break the above four types.
Chemical investigation of the roots of Polygala sibirica L.[Pubmed:24702811]
Chin J Nat Med. 2014 Mar;12(3):225-8.
AIM: To investigate the chemical constituents of the roots of Polygala sibirica L. (Polygalaceae) METHOD: The isolation was performed by solvent extraction and various chromatographic techniques, including silica gel, Sephadex LH-20, ODS, semi-preparative HPLC, and preparative TLC. The chemical structures were elucidated based on extensive spectroscopic analysis, including HR-ESI-MS and 1D- and 2D-NMR spectroscopic data. RESULTS: A total of sixteen compounds, including five xanthones (5, 7-10), five saccharide esters (1, 3, 4, 12, 13), two flavonoids (14, 16), two triterpenoids (11, 15), one phenylpropanoid (6), and one benzophenone glycoside (2) were isolated. Their structures were determined as sibiricose A7 (1), sibiriphenone A (2), polygalatenoside A (3), polygalatenoside C (4), Lancerin (5), 3, 4, 5-trimethoxycinnamic acid (6), 6-hydroxy-1, 2, 3, 7-tetramethoxyxanthone (7), 1, 3, 7-trihydroxy-2-methoxyxanthone (8), onjixanthone II (9), 1, 2, 3, 6, 7-pentamethoxyxanthone (10), presenegenin (11), 3'-O-3, 4, 5-trimethoxycinnamoyl-6-O-4-methoxy benzoyl sucrose (12), tenuifoliside C (13), 5, 3'-dihydroxy-7, 4'-dimethoxyflavonol-3-O-beta-D-glucopyranoside (14), tenuifolin (15), and rhamnetin 3-O-beta-D-glucopyranoside (16). CONCLUSION: Compounds 1 and 2 are two new compounds from P. sibirica.
Phenolic compounds from the whole plants of Gentiana rhodantha (Gentianaceae).[Pubmed:22006717]
Chem Biodivers. 2011 Oct;8(10):1891-900.
Gentiana rhodantha Franch. ex Hemsl. (Gentianaceae), an annual herb widely distributed in the southwest of China, has been medicinally used for the treatment of inflammation, cholecystitis, and tuberculosis by the local people of its growing areas. Chemical investigation on the whole plants led to the identification of eight new phenolic compounds, rhodanthenones A-D (1-4, resp.), apigenin 7-O-glucopyranosyl-(1-->3)-glucopyranosyl-(1-->3)-glucopyranoside (5), 1,2-dihydroxy-4-methoxybenzene 1-O-alpha-L-rhamnopyranosyl-(1-->6)-beta-D-glucopyranoside (6), 1,2-dihydroxy-4,6-dimethoxybenzene 1-O-alpha-L-rhamnopyranosyl-(1-->6)-beta-D-glucopyranoside (7), and methyl 2-O-beta-D-glucopyranosyl-2,4,6-trihydroxybenzoate (8), together with eleven known compounds, 9-19. Their structures were determined on the basis of detailed spectroscopic analyses and chemical methods. Acetylcholinesterase (AChE) inhibition and cytotoxicity tests against five human cancer cell lines showed that only rhodanthenone D (4) and mangiferin (12) exhibited 18.4 and 13.4% of AChE inhibitory effects at a concentration of 10(-4) M, respectively, while compounds 1-5 and the known xanthones Lancerin (11), mangiferin (12), and neomangiferin (13) displayed no cytotoxicity at a concentration of 40 muM.
Phytochemical re-investigation of Gentiana utriculosa.[Pubmed:19296391]
Nat Prod Res. 2009;23(5):466-9.
Xanthone-O-glycosides with 1,3,7,8-oxidation pattern and flavone isoorientin-3'-O-glucoside were isolated from the aerial parts of Gentiana utriculosa. Xanthone-C-glucoside Lancerin was detected in Gentiana species for the first time. The distribution of these compounds within the section Calathianae is discussed.
Xanthone glycosides from Polygala tenuifolia and their conformational analyses.[Pubmed:15974611]
J Nat Prod. 2005 Jun;68(6):875-9.
Seven xanthone glycosides were isolated from the cortexes of Polygala tenuifolia, and their structures were identified as polygalaxanthones VIII-XI (1-4), sibiricoxanthone B (5), 7-O-methylmangiferin (6), and Lancerin (7), on the basis of spectroscopic analyses. Compounds 1-4 are new xanthone glycosides, and compounds 4 and 5 exist as rotamers. To explain this phenomenon, conformational analyses were performed on compounds 4 and 5 and other compounds with similar skeletons that were isolated from P. tenuifolia.
Effects on anti-lipid peroxidation of Cudrania cochinchinensis var. gerontogea.[Pubmed:7853868]
J Ethnopharmacol. 1994 Oct;44(2):79-85.
From the root bark of Cudrania cochinchinensis (Lour.) Kudo et Masamune var. gerontogea (Sieb. et Zucc.) Kudo et Masamune, 3 xanthones, cudraxanthone I, 1,3,7-trihydroxy-2-(3-methylbut-2- enyl)-xanthone, and Lancerin, were further isolated and characterized. It was found that pretreatment with 600 mg/kg oral dose of the EtOH root extract of Cudrania cochinchinensis var. gerontogea in mice inhibited the lipid peroxidation stimulated by FeCl2-ascorbic acid-adenosine 5'-diphosphate (ADP) mixture. For searching bioactive constituents, the isolated xanthones from this folk medicine were investigated in anti-lipid peroxidative activities in the rat liver homogenate. The results showed that most of the tested xanthones effectively exhibited anti-lipid peroxidation stimulated by (a) FeCl2-ascorbic acid mixture or (b) CCl4-nicotinamide adenine dinucleotide phosphate (NADPH) mixture. As shown by the result, gerontoxanthone C and I were more active than vitamin E.